Table 4.
Fatty acid profile (µg/mg protein) of the erythrocyte plasma membrane in the placebo and Perilla frutescens leaf powder-intake groups.
| Baseline | 6-months | |||
|---|---|---|---|---|
| Placebo (n = 30) |
PLP (n = 30) |
Placebo (n = 25) |
PLP (n = 28) |
|
| PLA | 31.5 ± 1.7 | 34.1 ± 1.8 | 37.2 ± 1.0 | 37.9 ± 1.1 |
| STA | 24.9 ± 1.4 | 26.2 ± 1.4 | 29.9 ± 0.8 | 30.1 ± 0.9 |
| OLA | 18.6 ± 1.1 | 20.3 ± 1.1 | 23.8 ± 0.7 | 24.1 ± 0.7 |
| LLA | 13.9 ± 0.8 | 15.1 ± 0.9 | 17.7 ± 0.8 | 18.0 ± 0.9 |
| ALA | 0.37 ± 0.02 | 0.37 ± 0.02 | 0.26 ± 0.01 | 0.29 ± 0.01 * |
| AA | 16.7 ± 1.1 | 17.5 ± 1.1 | 20.7 ± 0.8 | 21.1 ± 0.8 |
| EPA | 2.0 ± 0.2 | 2.4 ± 0.2 | 2.8 ± 0.3 | 2.8 ± 0.2 |
| DPA | 3.1 ± 0.2 | 3.3 ± 0.2 | 3.8 ± 0.1 | 3.9 ± 0.1 |
| C24:0 | 8.3 ± 0.5 | 8.9 ± 0.5 | 9.9 ± 0.3 | 9.9 ± 0.3 |
| DHA | 11.1 ± 0.7 | 11.7 ± 0.8 | 12.7 ± 1.2 | 13.4 ± 0.6 |
| C24:1 | 7.7 ± 0.5 | 8.0 ± 0.5 | 9.9 ± 0.3 | 9.9 ± 0.3 |
| TFA | 138.2 ± 7.8 | 147.8 ± 8.1 | 168.5 ± 4.7 | 171.3 ± 5.0 |
Values are expressed as the standard error of mean (SEM). Placebo: the placebo group, PLP, Perilla frutescens leaf powder-intake group. AA, arachidonic acid; DHA, docosahexaenoic acid; DPA, docosapentaenoic acid; EPA, eicosapentaenoic acid; LLA, linoleic acid; ALA, α-linolenic acid; OLA, oleic acid; PLA, palmitic acid; STA, stearic acid; TFA; total fatty acids. * P < 0.05 compared with the placebo group.